Overview
- Siegwerk introduced inks formulated without mineral oils for pharmaceutical packaging in India, supported by a raw‑material approval process overseen by its global product safety team.
- The inks target reduced migration of mineral oil hydrocarbons, including MOAHs that are under international scrutiny due to potential carcinogenic risks.
- Several jurisdictions are weighing restrictions and some global brands already limit MOAHs, while India has no specific guidelines for pharma printing inks.
- The rollout follows a ₹350‑crore investment to expand Indian R&D, manufacturing and sustainability operations, with the business reporting revenues above ₹1,000 crore and long‑running operations in Bhiwadi.
- Siegwerk says the system bolsters consumer protection and helps Indian drugmakers meet overseas packaging requirements as the pharma‑packaging market is forecast to grow about 8.7% annually through 2030.